Blog Archives

Roche selects Vivonoetics and Great Lakes NeuroTechnologies to provide advanced respiratory assessment for the FIREFISH Phase II multicenter clinical trial in infants with Spinal Muscular Atrophy Type 1

31 JAN 2017: Orange County, CA – Vivonoetics Inc., developer of VivoSense® respiratory testing solutions, announced today that in partnership with Great Lakes NeuroTechnologies, they will be providing advanced respiratory assessment to the Roche FIREFISH study

Infants with Spinal muscular atrophy (SMA) develop respiratory insufficiency due to progressive respiratory muscle weakness caused by degeneration of alpha motor neurons in the spinal cord.

Read more ›



Great Lakes NeuroTechnologies Awarded Deep Brain Stimulation Programming Patent

VIEW PDF

11 JAN 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has been awarded Patent 9,522,278 (Movement Disorder Therapy System and Methods of Tuning Remotely, Intelligently and/or Automatically) from the US Patent Office, the seventh patent awarded to the company in 2016,

Read more ›



Great Lakes NeuroTech to collaborate with UCB on Wearables and Data Visualization Tools to help improve patient experiences for people with Parkinson’s Disease

Why Kinesia 360 Image

VIEW PDF

26 SEPT 2016: Valley View, OH – Great Lakes NeuroTech (GLNT) today announced plans to collaborate with the pharmaceutical company UCB to provide individuals with Parkinson’s Disease (PD) and their clinicians with improved quantitative tools for assessing the impact of their current treatment with the aim of providing better individual patient experiences and,

Read more ›



WEARABLE TECHNOLOGY IN PARKINSON’S DISEASE DEMONSTRATES INCREASED REFERRAL RATE FOR ADVANCED THERAPY

VIEW PDFK1

20 JUL 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has completed and published a clinical study validating that remote monitoring with wearable, objective measures can lead to an increased referral rate for advanced therapies in Parkinson’s disease.  The study “Wearable Sensors for Advanced Therapy Referral in Parkinson’s Disease,” was recently published in The Journal of Parkinson’s Disease [ http://www.ncbi.nlm.nih.gov/pubmed/27392872 ].

Read more ›



GREAT LAKES NEUROTECH VALIDATION STUDIES ON WEARABLE TECH FOR PARKINSON’S TO BE HIGHLIGHTED AT MOVEMENT DISORDER SOCIETY ANNUAL MEETING IN BERLIN

MDS Science

VIEW PDF

15 JUN 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that three scientific research studies validating Kinesia wearable tech for Parkinson’s disease applications will be highlighted at the 20th International Congress of Parkinson’s Disease and Movement Disorders in Berlin,

Read more ›



GREAT LAKES NEUROTECH ISSUED 4 PATENTS COVERING WEARABLES FOR MEASURING SYMPTOMS, ADJUSTING THERAPIES, AND DATABASE LEARNING IN PARKINSON’S DISEASE

VIEW PDF

10 JUN 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they PDApphave received four issued patents from the U.S. Patent Office, focused on wearable technology for Parkinson’s disease diagnostics and treatment. The issued intellectual property covers using wearable sensors for measuring motor symptoms associated with Parkinson’s disease,

Read more ›



Great Lakes NeuroTech Allowed Patent Claims for Deep Brain Stimulation Visualization Maps

VIEW PDF

14 OCT 2015: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they have received a new allowance of claims from the U.S. Patent Office, focused on technology for Parkinson’s disease diagnostics and treatment. This particular application covers a method of measuring Parkinson’s motor symptoms such as tremor,

Read more ›



Great Lakes NeuroTech Secures $1.9M for Closed-Loop Programming of Deep Brain Stimulation in Parkinson’s with Wearable Sensors

View PDF

KDBS621 SEP 2015: Cleveland, OH – Great Lakes NeuroTechnologies (GLNT), announced they have received $1.9M from the National Institutes of Health to improve the efficacy of deep brain stimulation (DBS) programming for Parkinson’s disease (PD) and minimize time required by a clinician to optimize settings.

Read more ›



Wearables and Apps for Parkinson’s disease: Why Big Data and Big Names May Not Be Small Enough

VIEW PRESS RELEASE PDF 

17 MAR 2015: Cleveland, OH – While headlines recently surged over big organizations such as Intel, Apple, and the Michael J. Fox Foundation partnering to launch pilot studies on wearables, mobile apps, and big data for Parkinson’s disease… a small,

Read more ›



PRESS RELEASE: Great Lakes NeuroTech Pilot Studies Demonstrate Computer Guided Algorithms for Programming Deep Brain Stimulation in Parkinson’s Disease

VIEW PRESS RELEASE PDF

06 FEB 2015: Valley View, OH – Great Lakes NeuroTechnologies announced today they have completed two pilot studies [ http://glneurotech.com/kinesia/validation/dbs-pilot-study/ ] demonstrating computer-guided algorithms for programming deep brain stimulation (DBS) in Parkinson’s disease. The first study, in collaboration with the University of Minnesota and recently accepted for publication in Parkinsonism and Related Disorders [ http://glneurotech.com/kinesia/publications/ ],

Read more ›



Top